The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels

Cytokine

Volumn 64, Issue 1, 2013, Pages 441-447

  Andrés Cerezo, Lucie ^a   Kuklová, Markéta ^a   Hulejová, Hana ^a   Vernerová, Zdeňka ^a   Pešáková, Vlasta ^a   Pecha, Ondřej ^a   Veigl, David ^a   Haluzík, Martin ^b   Pavelka, Karel ^a   Vencovský, Jiří ^a   Šenolt, Ladislav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

FABP4; Inflammation; Lipid profile; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID BINDING PROTEIN 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; B LYMPHOCYTE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; METABOLISM; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SYNOVIAL FLUID; SYNOVIUM; TRIACYLGLYCEROL BLOOD LEVEL;

FABP4; INFLAMMATION; LIPID PROFILE; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID-BINDING PROTEINS; FEMALE; FIBROBLASTS; HUMANS; LIPIDS; MACROPHAGES; MALE; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL FLUID; UP-REGULATION;

EID: 84883552339     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.05.001     Document Type: Article

References (31)

1. Gómez R., Conde J., Scotece M., Gómez-Reino J.J., Lago F., et al. What's new in our understanding of the role of adipokines in rheumatic diseases?. Nat Rev Rheumatol 2011, 7:528-536.
2. Schaffler A., Ehling A., Neumann E., Herfarth H., Tarner I., et al. Adipocytokines in synovial fluid. JAMA 2003, 290:1709-1710.
3. Bokarewa M., Bokarew D., Hultgren O., Tarkowski A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 2003, 62:952-956.
4. Otero M., Lago R., Gomez R., Lago F., Dieguez C., et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006, 65:1198-1201.
5. Senolt L., Housa D., Vernerova Z., Jirásek T., Svobodová R., et al. Resistin is abundantly present in rheumatoid arthritis synovial tissue, synovial fluid, and elevated serum resistin reflects disease activity. Ann Rheum Dis 2007, 66:458-463.
6. Brentano F., Schorr O., Ospelt C., Stanczyk J., Gay R.E., et al. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 2007, 56:2829-2839.
7. Senolt L., Pavelka K., Housa D., Haluzik M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 2006, 35:247-252.
8. Rho Y.H., Solus J., Sokka T., Oeser A., Chung C.P., et al. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 2009, 60:1906-1914.
9. Senolt L., Polanská M., Filková M., Cerezo L.A., Pavelka K., et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010, 69:1410-1411.
10. Xu A., Wang Y., Xu J.Y., Stejskal D., Tam S., et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006, 52:405-413.
11. Hotamisligil G.S., Johnson R.S., Distel R.J., Ellis R., Papaioannou V.E., et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996, 274:1377-1379.
12. Boord J.B., Fazio S., Linton M.F. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 2002, 13:141-147.
13. Cousin B., Munoz O., Andre M., Fontanilles A.M., Dani C., et al. A role for preadipocytes as macrophage-like cells. FASEB J 1999, 13:305-312.
14. Makowski L., Brittingham K.C., Reynolds J.M., Suttles J., Hotamisligil G.S. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and Iκ kinase activities. J Biol Chem 2005, 280:12888-12895.
15. Shum B.O., Mackay C.R., Gorgun C.Z., Frost M.J., Kumar R.K., et al. The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J Clin Invest 2006, 116:2183-2192.
16. Yang R., Castriota G., Chen Y., Cleary M.A., Ellsworth K., et al. RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice. Int J Obes (Lond) 2011, 35:217-225.
17. Khalyfa A., Bhushan B., Hegazi M., Kim J., Kheirandish-Gozal L., et al. Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels. Lipids Health Dis 2010, 15:9-18.
18. Terra X., Quintero Y., Auguet T., Porras J.A., Hernández M., et al. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol 2011, 164:539-547.
19. Bagheri R., Qasim A.N., Mehta N.N., Terembula K., Kapoor S., et al. Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus. Am J Cardiol 2010, 106:1118-1123.
20. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
21. Cabré A., Lázaro I., Cofán M., Jarauta E., Plana N., et al. FABP4 plasma levels are increased in familial combined hyperlipidemia. J Lipid Res 2010, 51:1173-1178.
22. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001, 4:499-502.
23. Fisher R.M., Thorne A., Hamsten A., Arner P. Fatty acid binding protein expression in different human adipose tissue depots in relation to rates of lipolysis and insulin concentration in obese individuals. Mol Cell Biochem 2002, 239:95-100.
24. Xu A., Chan K.W., Hoo R.L., Wang Y., Tan K.C., et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005, 280:18073-18080.
25. Holm S., Ueland T., Dahl T.B., Michelsen A.E., Skjelland M., Russell D., et al. Fatty acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke. PLoS ONE 2011, 6:e28785.
26. Giles J.T., Ling S.M., Ferrucci L., Bartlett S.J., Andersen R.E., Towns M., et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008, 59:807-815.
27. Chung C.P., Giles J.T., Petri M., Szklo M., Post W., Blumenthal R.S., et al. Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum 2012, 41:535-544.
28. Myasoedova E., Crowson C.S., Kremers H.M., Roger V.L., Fitz-Gibbon P.D., Therneau T.M., et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011, 70:482-487.
29. Bao Y., Lu Z., Zhou M., Li H., Wang Y., et al. Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women. PLoS ONE 2011, 6:e19115.
30. Lamounier-Zepter V., Look C., Alvarez J., Christ T., Ravens U., Schunck W.H., et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 2009, 105:326-334.
31. Gremese E., Ferraccioli G. The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev 2011, 10:582-589.